MustGrow Biologics Statistics

Total Valuation

FRA:0C0 has a market cap or net worth of EUR 23.36 million. The enterprise value is 21.68 million.

Market Cap	23.36M
Enterprise Value	21.68M

Important Dates

The last earnings date was Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	58.85M
Shares Outstanding	n/a
Shares Change (YoY)	+2.48%
Shares Change (QoQ)	+4.95%
Owned by Insiders (%)	11.61%
Owned by Institutions (%)	n/a
Float	50.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.06
PB Ratio	13.12
P/TBV Ratio	14.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.56
EV / Sales	4.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.42

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.20.

Current Ratio	1.89
Quick Ratio	1.15
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	-17.99

Financial Efficiency

Return on equity (ROE) is -202.96% and return on invested capital (ROIC) is -92.74%.

Return on Equity (ROE)	-202.96%
Return on Assets (ROA)	-65.98%
Return on Invested Capital (ROIC)	-92.74%
Return on Capital Employed (ROCE)	-178.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.45
Inventory Turnover	5.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.28%
50-Day Moving Average	0.39
200-Day Moving Average	0.52
Relative Strength Index (RSI)	44.20
Average Volume (20 Days)	1,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:0C0 had revenue of EUR 4.61 million and -3.90 million in losses. Loss per share was -0.07.

Revenue	4.61M
Gross Profit	570,854
Operating Income	-3.35M
Pretax Income	-3.90M
Net Income	-3.90M
EBITDA	n/a
EBIT	-3.35M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 2.01 million in cash and 357,179 in debt, giving a net cash position of 1.65 million.

Cash & Cash Equivalents	2.01M
Total Debt	357,179
Net Cash	1.65M
Net Cash Per Share	n/a
Equity (Book Value)	1.78M
Book Value Per Share	0.03
Working Capital	1.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.92 million and capital expenditures -6,618, giving a free cash flow of -2.92 million.

Operating Cash Flow	-2.92M
Capital Expenditures	-6,618
Free Cash Flow	-2.92M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 12.37%, with operating and profit margins of -72.64% and -84.52%.

Gross Margin	12.37%
Operating Margin	-72.64%
Pretax Margin	-84.52%
Profit Margin	-84.52%
EBITDA Margin	n/a
EBIT Margin	-72.64%
FCF Margin	n/a

Dividends & Yields

FRA:0C0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.48%
Shareholder Yield	-2.48%
Earnings Yield	-16.69%
FCF Yield	-12.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0C0 has an Altman Z-Score of 2.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	3